Literature DB >> 16051849

Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.

Mark P Dodding1, Michael Bock, Melvyn W Yap, Jonathan P Stoye.   

Abstract

Murine leukemia virus is restricted in mouse cells lines by a host factor known as Fv1 and in human cell lines by Ref1. Genetic evidence indicates that these restriction factors target the virus capsid (CA) protein. Restriction can be overcome by adding virus at a high multiplicity of infection, indicating that the restriction factors can be saturated. Cells preexposed to restricted virus will allow infection by a second virus which would normally be restricted. This phenomenon is known as abrogation; it provides us with a tool with which to study the interaction of virus with restriction factors. We tested the abilities of several Gag processing mutants to abrogate restriction. Our results show that CA must be cleaved from both p12 and nucleocapsid in order for the incoming virion to interact with the restriction factor. Endogenous expression of properly processed CA, however, failed to abrogate restriction. These results suggest that as well as being processed, CA must also be properly assembled in the form of a condensed viral core in order to interact with Fv1 and Ref1. This polymeric structure may contain restriction factor binding sites not present in monomeric CA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051849      PMCID: PMC1182663          DOI: 10.1128/JVI.79.16.10571-10577.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  High-resolution structure of a retroviral capsid hexameric amino-terminal domain.

Authors:  Gulnahar B Mortuza; Lesley F Haire; Anthony Stevens; Stephen J Smerdon; Jonathan P Stoye; Ian A Taylor
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

2.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 3.  Retrovirus restriction factors.

Authors:  Stephen P Goff
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

Review 4.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

5.  Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells.

Authors:  Brett M Forshey; Jiong Shi; Christopher Aiken
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

8.  Foamy virus capsids require the cognate envelope protein for particle export.

Authors:  T Pietschmann; M Heinkelein; M Heldmann; H Zentgraf; A Rethwilm; D Lindemann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

Authors:  U K von Schwedler; T L Stemmler; V Y Klishko; S Li; K H Albertine; D R Davis; W I Sundquist
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

10.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

View more
  26 in total

1.  How TRIM5alpha defends against retroviral invasions.

Authors:  Michael Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  The retroviral restriction factor TRIM5alpha.

Authors:  Sarah Sebastian; Jeremy Luban
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

3.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

4.  Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.

Authors:  Tsai-Yu Lin; Michael Emerman
Journal:  Virology       Date:  2008-08-03       Impact factor: 3.616

5.  The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.

Authors:  Xing Li; Joseph Sodroski
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

6.  Site-specific release of nascent chains from ribosomes at a sense codon.

Authors:  Victoria A Doronina; Cheng Wu; Pablo de Felipe; Matthew S Sachs; Martin D Ryan; Jeremy D Brown
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

7.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

8.  Capsid proteins from human immunodeficiency virus type 1 and simian immunodeficiency virus SIVmac can coassemble into mature cores of infectious viruses.

Authors:  Jianbo Chen; Vinay K Pathak; Weiqun Peng; Wei-Shau Hu
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Restriction of foamy viruses by primate Trim5alpha.

Authors:  Melvyn W Yap; Dirk Lindemann; Nicole Stanke; Juliane Reh; Dana Westphal; Helmut Hanenberg; Sadayuki Ohkura; Jonathan P Stoye
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.